ResearcherCedars-Sinai Medical CenterActive in the last 2 years
Hayato Muranaka
Matched on ORCID iD 0000-0003-4835-3836; OpenAlex author ID A5051440910. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 6
- L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 Glut… First author DOI 10.1038/s43018-026-01225-z↗
- Fecal Microbiome Composition and Plasma Metabolomics in Pancreatic Cancer Cachexia Treated with Nutritional Support Co-author DOI 10.20944/preprints202401.0727.v1↗
- Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensitivity Co-author DOI 10.21203/rs.3.rs-3647514/v1↗
- Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Co-author DOI 10.3390/biomedicines11051392↗
- Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers15113020↗
- Gut microbiome and pancreatic cancer cachexia: An evolving relationship. Co-author DOI 10.4251/wjgo.v14.i7.1218↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Neil A. Bhowmick · 6 shared papers, 2022–2026 · strength 1.05
- Paper L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma:… DOI 10.1038/s43018-026-01225-z↗
- Paper Fecal Microbiome Composition and Plasma Metabolomics in Pancreatic Cancer Cachexia Treated with Nutritional Support DOI 10.20944/preprints202401.0727.v1↗
- Paper Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. DOI 10.3390/cancers15113020↗
- Andrew Eugene Hendifar · 6 shared papers, 2022–2026 · strength 1.05
- Paper L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma:… DOI 10.1038/s43018-026-01225-z↗
- Paper Fecal Microbiome Composition and Plasma Metabolomics in Pancreatic Cancer Cachexia Treated with Nutritional Support DOI 10.20944/preprints202401.0727.v1↗
- Paper Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. DOI 10.3390/cancers15113020↗
- Jun Gong · 6 shared papers, 2022–2026 · strength 1.05
- Paper L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma:… DOI 10.1038/s43018-026-01225-z↗
- Paper Fecal Microbiome Composition and Plasma Metabolomics in Pancreatic Cancer Cachexia Treated with Nutritional Support DOI 10.20944/preprints202401.0727.v1↗
- Paper Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. DOI 10.3390/cancers15113020↗
- Arsen Osipov · 5 shared papers, 2022–2026 · strength 0.90
- Paper L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma:… DOI 10.1038/s43018-026-01225-z↗
- Paper Fecal Microbiome Composition and Plasma Metabolomics in Pancreatic Cancer Cachexia Treated with Nutritional Support DOI 10.20944/preprints202401.0727.v1↗
- Paper Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. DOI 10.3390/cancers15113020↗
- Stephen Jacob Pandol · 3 shared papers, 2023–2026 · strength 0.54
- Paper L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma:… DOI 10.1038/s43018-026-01225-z↗
- Paper Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. DOI 10.3390/cancers15113020↗
- Paper Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensit… DOI 10.21203/rs.3.rs-3647514/v1↗
- Natalie Moshayedi · 3 shared papers, 2022–2024 · strength 0.51
- Paper Fecal Microbiome Composition and Plasma Metabolomics in Pancreatic Cancer Cachexia Treated with Nutritional Support DOI 10.20944/preprints202401.0727.v1↗
- Paper Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. DOI 10.3390/cancers15113020↗
- Paper Gut microbiome and pancreatic cancer cachexia: An evolving relationship. DOI 10.4251/wjgo.v14.i7.1218↗
- Omer Hany Miligy Elmadbouh · 2 shared papers, 2023–2026 · strength 0.37
- Paper L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma:… DOI 10.1038/s43018-026-01225-z↗
- Paper Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensit… DOI 10.21203/rs.3.rs-3647514/v1↗
- Mouad Edderkaoui · 2 shared papers, 2023–2026 · strength 0.37
- Paper L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma:… DOI 10.1038/s43018-026-01225-z↗
- Paper Supraphysiological glutamine as a means of depleting intracellular amino acids to enhance pancreatic cancer chemosensit… DOI 10.21203/rs.3.rs-3647514/v1↗
- Veronica Placencio-Hickok · 2 shared papers, 2023–2024 · strength 0.37
- Nicholas P. Tatonetti · 1 shared paper, 2023 · strength 0.17
- Abrahm Levi · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.